Using bioinformatics analyses, we observed an inversed relationship between ERBB2 and ATM mRNA expressions across many TCGA‐analysed malignancies meaning that cancers expressing high ERBB2 mRNA levels tend to have lower ATM expression and this is obvious in bladder, breast, uterine corpus endometrial and thyroid cancers. Here, ERBB2 is linked to thyroid cancer.